Cite
APA Citation
Sivapalasingam, S., Kamal, M., Slim, R., Hosain, R., Shao, W., Stoltz, R., Yen, J., Pologe, L. G., Cao, Y., Partridge, M., Sumner, G., & Lipsich, L. (2018). safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study. Lancet infectious diseases, 18(8), 884–893. http://access.bl.uk/ark:/81055/vdc_100066543548.0x00000f